Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-04 Purchase | 2026-03-06 4:55 pm | Generate Biomedicines Inc. | GENB | Nally Michael Chief Executive Officer | 20,000 | $12 | $240,000 | 2,889,154 (Indirect Direct) | View |
| 2026-03-02 Purchase | 2026-03-02 6:05 pm | Generate Biomedicines Inc. | GENB | Grous Beth Chief People Officer | 300 | $16 | $4,800 | 114,320 (Indirect Direct) | View |
| 2026-03-02 Purchase | 2026-03-02 5:54 pm | Generate Biomedicines Inc. | GENB | Silvers Jason President & CFO | 2,000 | $16 | $32,000 | 571,101 (Indirect Direct) | View |
| 2026-03-02 Purchase | 2026-03-02 5:52 pm | Generate Biomedicines Inc. | GENB | AFEYAN NOUBAR Flagship Pioneering LLC Flagship VentureLabs VI Manager LLC Flagship Pioneering Fund VI General Partner LLC Flagship Pioneering Fund VII General Partner LLC Nutritional Health LTP Fund General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC FPN General Partner LLC Director 10% Owner | 4,687,500 | $16 | $75,000,000 | 26,608,519 (Indirect Direct) | View |
| 2026-03-02 Purchase | 2026-03-02 5:47 pm | Generate Biomedicines Inc. | GENB | Mendillo Jane L Director | 1,500 | $16 | $24,000 | 31,061 (Direct) | View |
| 2026-03-02 Purchase | 2026-03-02 5:42 pm | Generate Biomedicines Inc. | GENB | AFEYAN NOUBAR Flagship VentureLabs VI LLC Flagship Pioneering Fund VI L.P. Flagship Pioneering Fund VII L.P. Nutritional Health LTP Fund L.P. Flagship Pioneering Special Opportunities Fund II L.P. FPN II L.P. Director 10% Owner | 4,687,500 | $16 | $75,000,000 | 26,608,519 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-03-12 5:00 pm | N/A N/A | Generate Biomedicines Inc. | GENB | Pioneering Medicines 02 LLC 10% Owner | 0 | $0 | 1,562,500 (Indirect) | View |
| 2026-02-26 Option Award | 2026-03-02 6:09 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | Vessey Rupert Director | 29,561 | $0 | 29,561 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 6:05 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | Grous Beth Chief People Officer | 114,020 | $0 | 114,320 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 6:02 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | ARNOLD FRANCES Director | 29,561 | $0 | 29,561 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:58 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | Lee Laurie Anne Chief Medical Officer | 42,230 | $0 | 42,230 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:58 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | Martin Sean Chief Legal Officer & GC | 190,034 | $0 | 190,034 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:55 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | Simonian Nancy A Director | 29,561 | $0 | 29,561 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:54 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | Silvers Jason President & CFO | 570,101 | $0 | 571,101 (Direct) | View |
| 2026-03-02 Conversion | 2026-03-02 5:52 pm | N/A N/A | Generate Biomedicines Inc. | GENB | AFEYAN NOUBAR Flagship Pioneering LLC Flagship VentureLabs VI Manager LLC Flagship Pioneering Fund VI General Partner LLC Flagship Pioneering Fund VII General Partner LLC Nutritional Health LTP Fund General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC FPN General Partner LLC Director 10% Owner | 80,271,570 | $0 | 26,608,519 (Indirect) | View |
| 2026-02-26 Option Award | 2026-03-02 5:52 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | AFEYAN NOUBAR Flagship Pioneering LLC Flagship VentureLabs VI Manager LLC Flagship Pioneering Fund VI General Partner LLC Flagship Pioneering Fund VII General Partner LLC Nutritional Health LTP Fund General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC FPN General Partner LLC Director 10% Owner | 29,561 | $0 | 26,608,519 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:51 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | Grigoryan Gevorg Chief Technology Officer | 491,976 | $0 | 491,976 (Direct) | View |
| 2026-03-02 Conversion | 2026-03-02 5:50 pm | N/A N/A | Generate Biomedicines Inc. | GENB | Nally Michael Chief Executive Officer | 1,658,327 | $0 | 4,558,344 (Indirect) | View |
| 2026-02-26 Option Award | 2026-03-02 5:50 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | Nally Michael Chief Executive Officer | 1,689,190 | $0 | 4,558,344 (Direct) | View |
| 2026-03-02 Conversion | 2026-03-02 5:50 pm | N/A N/A | Generate Biomedicines Inc. | GENB | Bancel Stephane Director | 1,824,160 | $0 | 1,214,550 (Indirect) | View |
| 2026-02-26 Option Award | 2026-03-02 5:50 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | Bancel Stephane Director | 29,561 | $0 | 1,214,550 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:47 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | Mendillo Jane L Director | 29,561 | $0 | 31,061 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:47 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | Fanucci Marsha Director | 29,561 | $0 | 29,561 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 5:45 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | Parker Paul Gray Director | 29,561 | $0 | 29,561 (Direct) | View |
| 2026-03-02 Conversion | 2026-03-02 5:42 pm | N/A N/A | Generate Biomedicines Inc. | GENB | AFEYAN NOUBAR Flagship VentureLabs VI LLC Flagship Pioneering Fund VI L.P. Flagship Pioneering Fund VII L.P. Nutritional Health LTP Fund L.P. Flagship Pioneering Special Opportunities Fund II L.P. FPN II L.P. Director 10% Owner | 80,271,570 | $0 | 26,608,519 (Indirect) | View |
| 2026-02-26 Option Award | 2026-03-02 5:42 pm | N/A 2036-02-25 | Generate Biomedicines Inc. | GENB | AFEYAN NOUBAR Flagship VentureLabs VI LLC Flagship Pioneering Fund VI L.P. Flagship Pioneering Fund VII L.P. Nutritional Health LTP Fund L.P. Flagship Pioneering Special Opportunities Fund II L.P. FPN II L.P. Director 10% Owner | 29,561 | $0 | 26,608,519 (Direct) | View |
Ownership | 2026-02-26 9:50 pm | N/A N/A | Generate Biomedicines Inc. | GENB | AFEYAN NOUBAR Flagship Pioneering LLC Flagship VentureLabs VI Manager LLC Flagship Pioneering Fund VI General Partner LLC Flagship Pioneering Fund VII General Partner LLC Nutritional Health LTP Fund General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC FPN General Partner LLC Director 10% Owner | 0 | $0 | 58,051,449 (Indirect) | View |
Ownership | 2026-02-26 9:48 pm | N/A N/A | Generate Biomedicines Inc. | GENB | AFEYAN NOUBAR Flagship VentureLabs VI LLC Flagship Pioneering Fund VI L.P. Flagship Pioneering Fund VII L.P. Nutritional Health LTP Fund L.P. Flagship Pioneering Special Opportunities Fund II L.P. FPN II L.P. Director 10% Owner | 0 | $0 | 58,051,449 (Indirect) | View |
Ownership | 2026-02-26 9:11 pm | N/A N/A | Generate Biomedicines Inc. | GENB | Nally Michael Chief Executive Officer | 0 | $0 | 7,785,214 (Direct) | View |
Ownership | 2026-02-26 8:51 pm | N/A 2032-08-05 | Generate Biomedicines Inc. | GENB | Martin Sean Chief Legal Officer & GC | 0 | $0 | 1,170,505 (Direct) | View |
Ownership | 2026-02-26 8:50 pm | N/A 2032-09-29 | Generate Biomedicines Inc. | GENB | Silvers Jason President & CFO | 0 | $0 | 1,351,546 (Direct) | View |
Ownership | 2026-02-26 8:49 pm | N/A 2035-06-04 | Generate Biomedicines Inc. | GENB | Parker Paul Gray Director | 0 | $0 | 131,665 (Direct) | View |
Ownership | 2026-02-26 8:48 pm | N/A 2034-07-03 | Generate Biomedicines Inc. | GENB | Simonian Nancy A Director | 0 | $0 | 131,665 (Direct) | View |
Ownership | 2026-02-26 8:48 pm | N/A 2032-12-12 | Generate Biomedicines Inc. | GENB | Mendillo Jane L Director | 0 | $0 | 164,581 (Direct) | View |
Ownership | 2026-02-26 8:46 pm | N/A 2035-09-15 | Generate Biomedicines Inc. | GENB | Lee Laurie Anne Chief Medical Officer | 0 | $0 | 197,498 (Direct) | View |
Ownership | 2026-02-26 8:46 pm | N/A N/A | Generate Biomedicines Inc. | GENB | Grigoryan Gevorg Chief Technology Officer | 0 | $0 | 1,285,382 (Direct) | View |
Ownership | 2026-02-26 8:42 pm | N/A 2033-12-03 | Generate Biomedicines Inc. | GENB | Grous Beth Chief People Officer | 0 | $0 | 822,908 (Direct) | View |
Ownership | 2026-02-26 8:41 pm | N/A N/A | Generate Biomedicines Inc. | GENB | Bancel Stephane Director | 0 | $0 | 1,283,737 (Direct) | View |
Ownership | 2026-02-26 8:39 pm | N/A 2034-07-03 | Generate Biomedicines Inc. | GENB | Vessey Rupert Director | 0 | $0 | 131,665 (Direct) | View |
Ownership | 2026-02-26 8:37 pm | N/A 2036-02-02 | Generate Biomedicines Inc. | GENB | Khakoo Aarif Chief Scientific Officer | 0 | $0 | 394,996 (Direct) | View |
Ownership | 2026-02-26 8:26 pm | N/A N/A | Generate Biomedicines Inc. | GENB | ARNOLD FRANCES Director | 0 | $0 | 563,692 (Direct) | View |
Ownership | 2026-02-26 8:23 pm | N/A 2035-03-10 | Generate Biomedicines Inc. | GENB | Fanucci Marsha Director | 0 | $0 | 131,665 (Direct) | View |